Hillel Grossman MD
Assistant Professor, Psychiatry, Icahn School of Medicine, Mount Sinai. Co-Director, Clinical Research Core of the Alzheimer's Disease Research Center. Clinical Director of the Mount Sinai Memory and Aging Center.
Join to view full profile
James J Peters VAMC130 West Kingsbridge RoadBronx, NY 10468
Dr. Grossman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Psychiatry, 1986 - 1990
University of Tennessee Health Science Center College of MedicineClass of 1986
Certifications & Licensure
NY State Medical License 1990 - 2027
MA State Medical License 1993 - 2002
MD State Medical License 1988 - 1990
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
Publications & Presentations
PubMed
- 2 citationsUnderstanding the Role of Neuropsychiatric Symptoms in Functional Decline in Alzheimer's Disease.Carolyn W Zhu, Lon S Schneider, Laili Soleimani, Judith Neugroschl, Hillel T Grossman
The Journal of Neuropsychiatry and Clinical Neurosciences. 2026-01-01 - 10 citationsNeuropsychiatric Symptom Profile in Alzheimer's Disease and Their Relationship With Functional Decline.Carolyn W Zhu, Lon S Schneider, Gregory A Elder, Laili Soleimani, Hillel T Grossman
The American Journal of Geriatric Psychiatry. 2024-12-01 - Clinical Manifestations.Carolyn W Zhu, Lon S S Schneider, Amy Aloysi, Gregory Elder, Hillel Grossman
Alzheimer's & Dementia. 2024-12-01
Press Mentions
Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
Association of Altered Liver Enzymes with AD, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid BiomarkersJuly 31st, 2019
Grant Support
- Phase 11-Grape Seed Extract As Anti-Oligomerization Agent In Alzheimer'S DiseaseNational Center For Complementary &Alternative Medicine2010
- Development Of D-Pinitol In The Treatment Of Alzheimer'S DiseaseNational Center For Research Resources2008–2009
- Alzheimer'S Disease Neuroimaging InitiativeNational Center For Research Resources2007–2008
- Pilot Studies Of The Nutritional Supplement D-Pinitol In Alzheimer'S DiseaseNational Center For Complementary &Alternative Medicine2006–2008
- Pilot Studies Of The Nutritional Supplement Nic5-15 In Alzheimers DiseaseNational Center For Complementary &Alternative Medicine2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
